866-997-4948(US-Canada Toll Free)

Global Erythropoietin Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 111 Pages

This report studies the global market size of Erythropoietin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erythropoietin in these regions.
This research report categorizes the global Erythropoietin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

The classification of erythropoietin includes epoetin-alfa, epoetin-beta, darbepoetin-alfa and others. The proportion of epoetin-alfa in 2016 is about 58.53%.
Erythropoietin is widely used for anemia and kidney disorders. The most proportion of Erythropoietin used in Kidney Disorders, and the market share in 2016 is 45.91%.
In 2017, the global Erythropoietin market size was 7240 million US$ and is forecast to 10700 million US in 2025, growing at a CAGR of 5.8% from 2018. The objectives of this study are to define, segment, and project the size of the Erythropoietin market based on company, product type, application and key regions.

The various contributors involved in the value chain of Erythropoietin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Erythropoietin include
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

Market Size Split by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Market Size Split by Application
Anemia
Kidney Disorders
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Erythropoietin market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Erythropoietin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Erythropoietin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Erythropoietin with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Erythropoietin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Erythropoietin are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Erythropoietin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Erythropoietin Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Erythropoietin Market Size Growth Rate by Type
1.4.2 Epoetin-alfa
1.4.3 Epoetin-beta
1.4.4 Darbepoetin-alfa
1.4.5 Others
1.5 Market by Application
1.5.1 Global Erythropoietin Market Size Growth Rate by Application
1.5.2 Anemia
1.5.3 Kidney Disorders
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Erythropoietin Market Size
2.1.1 Global Erythropoietin Revenue 2016-2025
2.1.2 Global Erythropoietin Sales 2016-2025
2.2 Erythropoietin Growth Rate by Regions
2.2.1 Global Erythropoietin Sales by Regions
2.2.2 Global Erythropoietin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Erythropoietin Sales by Manufacturers
3.1.1 Erythropoietin Sales by Manufacturers
3.1.2 Erythropoietin Sales Market Share by Manufacturers
3.1.3 Global Erythropoietin Market Concentration Ratio (CR5 and HHI)
3.2 Erythropoietin Revenue by Manufacturers
3.2.1 Erythropoietin Revenue by Manufacturers (2016-2018)
3.2.2 Erythropoietin Revenue Share by Manufacturers (2016-2018)
3.3 Erythropoietin Price by Manufacturers
3.4 Erythropoietin Manufacturing Base Distribution, Product Types
3.4.1 Erythropoietin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Erythropoietin Product Category
3.4.3 Date of International Manufacturers Enter into Erythropoietin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Erythropoietin Sales by Type
4.2 Global Erythropoietin Revenue by Type
4.3 Erythropoietin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Erythropoietin Breakdown Data by Application

6 North America
6.1 North America Erythropoietin by Countries
6.1.1 North America Erythropoietin Sales by Countries
6.1.2 North America Erythropoietin Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Erythropoietin by Type
6.3 North America Erythropoietin by Application
6.4 North America Erythropoietin by Company

7 Europe
7.1 Europe Erythropoietin by Countries
7.1.1 Europe Erythropoietin Sales by Countries
7.1.2 Europe Erythropoietin Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Erythropoietin by Type
7.3 Europe Erythropoietin by Application
7.4 Europe Erythropoietin by Company

8 Asia Pacific
8.1 Asia Pacific Erythropoietin by Countries
8.1.1 Asia Pacific Erythropoietin Sales by Countries
8.1.2 Asia Pacific Erythropoietin Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Erythropoietin by Type
8.3 Asia Pacific Erythropoietin by Application
8.4 Asia Pacific Erythropoietin by Company

9 Central & South America
9.1 Central & South America Erythropoietin by Countries
9.1.1 Central & South America Erythropoietin Sales by Countries
9.1.2 Central & South America Erythropoietin Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Erythropoietin by Type
9.3 Central & South America Erythropoietin by Application
9.4 Central & South America Erythropoietin by Company

10 Middle East and Africa
10.1 Middle East and Africa Erythropoietin by Countries
10.1.1 Middle East and Africa Erythropoietin Sales by Countries
10.1.2 Middle East and Africa Erythropoietin Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Erythropoietin by Type
10.3 Middle East and Africa Erythropoietin by Application
10.4 Middle East and Africa Erythropoietin by Company

11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Erythropoietin
11.1.4 Erythropoietin Product Description
11.1.5 Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Erythropoietin
11.2.4 Erythropoietin Product Description
11.2.5 Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Erythropoietin
11.3.4 Erythropoietin Product Description
11.3.5 Recent Development
11.4 Galenica
11.4.1 Galenica Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Erythropoietin
11.4.4 Erythropoietin Product Description
11.4.5 Recent Development
11.5 Emcure
11.5.1 Emcure Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Erythropoietin
11.5.4 Erythropoietin Product Description
11.5.5 Recent Development
11.6 Kyowa Hakko Kirin
11.6.1 Kyowa Hakko Kirin Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Erythropoietin
11.6.4 Erythropoietin Product Description
11.6.5 Recent Development
11.7 3SBio
11.7.1 3SBio Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Erythropoietin
11.7.4 Erythropoietin Product Description
11.7.5 Recent Development
11.8 Biocon
11.8.1 Biocon Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Erythropoietin
11.8.4 Erythropoietin Product Description
11.8.5 Recent Development
11.9 LG Life Sciences
11.9.1 LG Life Sciences Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Erythropoietin
11.9.4 Erythropoietin Product Description
11.9.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Erythropoietin Raw Material
13.1.2 Erythropoietin Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Erythropoietin
Figure Global Erythropoietin Production (M Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Erythropoietin Production Market Share by Types (Product Category) in 2017
Figure Epoetin-alfa Product Picture
Table Major Manufacturers of Epoetin-alfa
Figure Epoetin-beta Product Picture
Table Major Manufacturers of Epoetin-beta
Figure Darbepoetin-alfa Product Picture
Table Major Manufacturers of Darbepoetin-alfa
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Erythropoietin Market Size Growth Rate by Application 2018-2025 (M Units)
Figure Anemia
Figure Kidney Disorders
Figure Others
Figure Erythropoietin Report Years Considered
Figure Global Erythropoietin Market Size 2016-2025 (Million US$)
Figure Global Erythropoietin Sales 2016-2025 (M Units)
Table Global Erythropoietin Market Size by Regions 2016-2025 (M Units) & (Million US$)
Table Global Erythropoietin Sales by Regions 2016-2025 (M Units)
Table Global Erythropoietin Sales Market Share by Regions 2016-2025
Figure Global Erythropoietin Sales Market Share by Regions 2016-2025
Figure 2017 Global Erythropoietin Sales Market Share by Regions
Table Global Erythropoietin Revenue by Regions 2016-2025 (Million US$)
Table Global Erythropoietin Revenue Market Share by Regions 2016-2025
Figure Global Erythropoietin Revenue Market Share by Regions 2016-2025
Figure 2017 Global Erythropoietin Revenue Market Share by Regions
Table Global Erythropoietin Sales by Manufacturers (2016-2018) (M Units)
Table Global Erythropoietin Sales Share by Manufacturers (2016-2018)
Figure Global Erythropoietin Sales Share by Manufacturers in 2017
Table Erythropoietin Revenue by Manufacturers (2016-2018) (Million US$)
Table Erythropoietin Revenue Share by Manufacturers (2016-2018)
Figure Erythropoietin Value Share by Manufacturers in 2017
Table Global Erythropoietin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Erythropoietin Price (2016-2018) (USD/Unit)
Table Erythropoietin Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Erythropoietin Product Category
Table Date of International Manufacturers Enter into Erythropoietin Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Erythropoietin Sales by Type (2016-2025) (M Units)
Table Global Erythropoietin Sales Share by Type (2016-2025)
Figure Global Erythropoietin Sales Market Share by Type (2016-2025)
Figure Global Erythropoietin Sales Market Share by Type in 2017
Table Global Erythropoietin Revenue by Type (2016-2025) (Million US$)
Table Global Erythropoietin Revenue Share by Type (2016-2025)
Figure Global Erythropoietin Revenue Market Share by Type (2016-2025)
Figure Global Erythropoietin Revenue Market Share by Type in 2017
Table Erythropoietin Price by Type 2013-2018 (USD/Unit)
Table Global Erythropoietin Sales by Application (2016-2025) (M Units)
Table Global Erythropoietin Sales Share by Application (2016-2025)
Figure Global Sales Erythropoietin Market Share by Application (2016-2025)
Figure Global Sales Erythropoietin Market Share by Application (2016-2025)
Figure North America Erythropoietin Sales Growth Rate 2016-2025 (M Units)
Figure North America Erythropoietin Revenue Growth Rate 2016-2025 (Million US$)
Table North America Erythropoietin Sales by Countries (2016-2025) (M Units)
Table North America Erythropoietin Sales Market Share by Countries (2016-2025)
Figure 2017 North America Erythropoietin Sales Market Share by Countries
Table North America Erythropoietin Revenue by Countries (2016-2025) (Million US$)
Table North America Erythropoietin Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Erythropoietin Revenue Market Share by Countries
Figure United States Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure United States Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Canada Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Mexico Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Table North America Erythropoietin Sales by Type (2016-2025) (M Units)
Table North America Erythropoietin Sales Market Share by Type (2016-2025)
Figure 2017 North America Erythropoietin Market Share by Type
Table North America Erythropoietin Sales by Application (2016-2025) (M Units)
Table North America Erythropoietin Sales Market Share by Application (2016-2025)
Figure 2017 North America Erythropoietin Market Share by Application
Table North America Erythropoietin Sales by Company (2016-2018) (M Units)
Table North America Erythropoietin Sales Market Share by Company (2016-2018)
Figure North America Erythropoietin Sales Market Share by Company in 2017
Figure Europe Erythropoietin Sales Growth Rate 2016-2025 (M Units)
Figure Europe Erythropoietin Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Erythropoietin Sales by Countries (2016-2025) (M Units)
Table Europe Erythropoietin Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Erythropoietin Sales Market Share by Countries
Table Europe Erythropoietin Revenue by Countries (2016-2025) (Million US$)
Table Europe Erythropoietin Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Erythropoietin Revenue Market Share by Countries
Figure Germany Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Germany Erythropoietin Revenue Growth Rate (2016-2025) (M Units)
Figure France Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure France Erythropoietin Revenue Growth Rate (2016-2025) (M Units)
Figure UK Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure UK Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Italy Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Russia Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Erythropoietin Sales by Type (2016-2025) (M Units)
Table Europe Erythropoietin Sales Market Share by Type (2016-2025)
Figure 2017 Europe Erythropoietin Market Share by Type
Table Europe Erythropoietin Sales by Application (2016-2025) (M Units)
Table Europe Erythropoietin Sales Market Share by Application (2016-2025)
Figure 2017 Europe Erythropoietin Market Share by Application
Table Europe Erythropoietin Sales by Company (2016-2018) (M Units)
Table Europe Erythropoietin Sales Market Share by Company (2016-2018)
Figure Europe Erythropoietin Sales Market Share by Company in 2017
Figure Asia Pacific Erythropoietin Sales Growth Rate 2016-2025 (M Units)
Figure Asia Pacific Erythropoietin Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Erythropoietin Sales by Countries (2016-2025) (M Units)
Table Asia Pacific Erythropoietin Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Erythropoietin Sales Market Share by Countries
Table Asia Pacific Erythropoietin Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Erythropoietin Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Erythropoietin Revenue Market Share by Countries
Figure China Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure China Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Japan Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Korea Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure India Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure India Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Australia Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Indonesia Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Malaysia Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Philippines Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Thailand Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Vietnam Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Singapore Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Erythropoietin Sales by Type (2016-2025) (M Units)
Table Asia Pacific Erythropoietin Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Erythropoietin Market Share by Type
Table Asia Pacific Erythropoietin Sales by Application (2016-2025) (M Units)
Table Asia Pacific Erythropoietin Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Erythropoietin Market Share by Application
Table Asia Pacific Erythropoietin Sales by Company (2016-2018) (M Units)
Table Asia Pacific Erythropoietin Sales Market Share by Company (2016-2018)
Figure Asia Pacific Erythropoietin Sales Market Share by Company in 2017
Figure Central & South America Erythropoietin Sales Growth Rate 2016-2025 (M Units)
Figure Central & South America Erythropoietin Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Erythropoietin Sales by Countries (2016-2025) (M Units)
Table Central & South America Erythropoietin Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Erythropoietin Sales Market Share by Countries
Table Central & South America Erythropoietin Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Erythropoietin Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Erythropoietin Revenue Market Share by Countries
Figure Brazil Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Brazil Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Argentina Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Erythropoietin Sales by Type (2016-2025) (M Units)
Table Central & South America Erythropoietin Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Erythropoietin Market Share by Type
Table Central & South America Erythropoietin Sales by Application (2016-2025) (M Units)
Table Central & South America Erythropoietin Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Erythropoietin Market Share by Application
Table Central & South America Erythropoietin Sales by Company (2016-2018) (M Units)
Table Central & South America Erythropoietin Sales Market Share by Company (2016-2018)
Figure Central & South America Erythropoietin Sales Market Share by Company in 2017
Figure Middle East and Africa Erythropoietin Sales Growth Rate 2016-2025 (M Units)
Figure Middle East and Africa Erythropoietin Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Erythropoietin Sales by Countries (2016-2025) (M Units)
Table Middle East and Africa Erythropoietin Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Erythropoietin Sales Market Share by Countries
Table Middle East and Africa Erythropoietin Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Erythropoietin Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Erythropoietin Revenue Market Share by Countries
Figure GCC Countries Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure GCC Countries Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Turkey Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure Egypt Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Erythropoietin Sales Growth Rate (2016-2025) (M Units)
Figure South Africa Erythropoietin Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Erythropoietin Sales by Type (2016-2025) (M Units)
Table Middle East and Africa Erythropoietin Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Erythropoietin Market Share by Type
Table Middle East and Africa Erythropoietin Sales by Application (2016-2025) (M Units)
Table Middle East and Africa Erythropoietin Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Erythropoietin Market Share by Application
Table Middle East and Africa Erythropoietin Sales by Company (2016-2018) (M Units)
Table Middle East and Africa Erythropoietin Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Erythropoietin Sales Market Share by Company in 2017
Table Amgen Company Details
Table Amgen Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Roche Company Details
Table Roche Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Galenica Company Details
Table Galenica Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Galenica Recent Development
Table Emcure Company Details
Table Emcure Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Emcure Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Kyowa Hakko Kirin Recent Development
Table 3SBio Company Details
Table 3SBio Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table 3SBio Recent Development
Table Biocon Company Details
Table Biocon Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Biocon Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Erythropoietin Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table LG Life Sciences Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Erythropoietin Value Chain
Table Typical Suppliers of Key Erythropoietin Raw Material
Table Erythropoietin Customers List
Table Erythropoietin Sales Channels
Table Erythropoietin Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *